CorePlus, Puerto Rico's fully digital precision pathology and clinical laboratory, announced today the integration of the ArteraAI Prostate Test into its diagnostic workflows, becoming the first ...

Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage, AI-driven precision oncology company, today announced the launch of ZetaOmics, the computational-biology module of its multi-agentic AI ...

The patented platform combines genome sequencing, methylation analysis and machine learning to detect cancer and identify its ...

The test, which is being trialled by two NHS trusts, could replace the transvaginal ultrasound scan in some cases ...

In a significant step towards advancing early cancer detection in India, Strand Life Sciences, a subsidiary of Reliance ...

Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection technology ...

In a significant breakthrough for cancer diagnostics, Reliance Industries subsidiary Strand Life Sciences has secured an Indian patent for an artificial intelligence-powered technology that can detect ...

Reliance’s Strand Life Sciences patents a blood-based technology for early cancer detection, enhancing accuracy and accessibility.

Patented platform uses cell-free DNA analysis and machine learning to detect cancer early and identify tissue of origin from ...

For more than a century, tissue biopsies have stood as the gold standard for diagnosing cancer. And for good reason. These ...

High-resolution spatial transcriptomics and imaging-based technologies are now generating large-scale, multi-dimensional datasets that are beginning to reshape how we understand tissue organisation, ...